secwatch.observer — SEC 8-K summary
======================================

Issuer:     BELLICUM PHARMACEUTICALS, INC (—)
CIK:        0001358403
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001628280-23-020619
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bellicum Pharma terminates CEO Richard Fair and CDO Charity Scripture; effective June 30, 2023
--------------------------------------------------------------------------------

- CEO Richard Fair and CDO Charity Scripture notified on May 31 that employment ends June 30, 2023.
- Both receive severance per agreements; Scripture gets COBRA reimbursement for up to 12 months.
- Both will sign consulting agreements to continue as officers as consultants on hourly basis.
- Severance conditioned on providing a general release of claims for the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1358403/000162828023020619/0001628280-23-020619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1358403/000162828023020619/blcm-20230602.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-020619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer